US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme
Pfizer buys stake in French vaccine maker Valneva
Related Posts
KKR, Temasek look to buy India’s TPG-backed Care Hospitals [Private Equity Insights]
U.S. investment firm KKR, Singapore’s Temasek Holdings, and India’s Max Healthcare Institute are vying to buy TPG-backed chain of Care Hospitals in a deal worth over $1bn, Mint newspaper...
Humana, CVS Circle Cano Health as Potential Buyers [Deals – News, Articles, Biography, Photos – WSJ.com]
Cano shares, which had been down nearly 7%, turned positive and closed up 32% after The Wall Street Journal reported on the talks with Humana and other unnamed parties, giving the company a market...
Pfizer Completes Acquisition of Global Blood Therapeutics [Business Wire Merger/Acquisition News]
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery,...